Status:
COMPLETED
Pre-operative Risk Assessment Combined With Targeted Intervention in the Chinese Elderly With Spine Surgery
Lead Sponsor:
Xuanwu Hospital, Beijing
Conditions:
Spine Degeneration
Spine Fusion
Eligibility:
All Genders
75+ years
Phase:
NA
Brief Summary
With the extended life expectancy of the Chinese population and improvements in surgery and anesthesia techniques, the number of aged patients undergoing surgery has been increasing annually. However,...
Detailed Description
According to the United Nations 2022 Revision of World Population Prospects, the proportion of people over 65 years of age is expected to increase from approximately 9.7% in 2022 to 16.4% in 2050. The...
Eligibility Criteria
Inclusion
- patients who voluntarily sign the informed consent form; (2) elective spinal fusion surgery for degenerative spinal disorders; (3) no severe cognitive impairment (MoCA score ≥ 8).
Exclusion
- Patients (1) are scheduled to undergo emergency or day surgery,
- have urgent condition that needs to be managed before the surgery,
- are unable to cooperate with preoperative assessment,
- have spinal fractures, metastasis, and spinal infections,
- unable to understand or participate safely in intervention program,
- participate in another study that may affect the study.
Key Trial Info
Start Date :
April 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 10 2025
Estimated Enrollment :
164 Patients enrolled
Trial Details
Trial ID
NCT06140797
Start Date
April 15 2024
End Date
September 10 2025
Last Update
September 23 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University First Hospital
Beijing, Beijing Municipality, China, 10034
2
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 10050
3
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 10053